UNSPSC 51311812: Emedastine fumarate

This classification denotes a histamine-1 receptor antagonist with the molecular formula C17H26N4O.2C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 42MB94QOSM. European Medicines Agency schedules emedastine fumarate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01874MIG. Most nations, for tariff and trade purposes, schedule emedastine fumarate under HS 29339940 and SITC 51577. SMILES: CCOCCN1C(NC2C1CCCC2)N3CCN(CCC3)C.C(=C/C(=O)O)\C(=O)O.C(=C/C(=O)O)\C(=O)O.

UNSPSC 51311812 Emedastine fumarate is a Commodity code that nominally covers a specific ophthalmic antihistamine drug product, but recent state and local solicitations show minimal direct purchasing activity aligned with this narrow pharmaceutical specification. The recent opportunities tagged to this code instead reflect broader pharmaceutical procurement across generic multi-source drugs, naloxone, and pharmacy benefit program implementation — categories that diverge significantly from emedastine fumarate's therapeutic and chemical identity. State and local governments purchasing under this code tier are predominantly health and human services agencies, cooperative purchasing alliances, and county health departments seeking to establish supply agreements for pharmaceutical products through competitive bidding processes, with vendors required to demonstrate FDA compliance, cGMP certification, Drug Supply Chain Security Act adherence, and established relationships with authorized pharmaceutical wholesalers.

Activity is concentrated in the upper Midwest and Florida. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities including Oregon, requiring vendors to maintain contracts with authorized wholesalers including AmerisourceBergen, Cardinal Health, and Morris & Dickson. Seminole County, Florida released IFB 60459723LAS on June 30, 2026 (response due July 26, 2026 at 2:00 pm) seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries, including all shipping costs. The Texas Health and Human Services Commission issued an exploratory RFI (HHS0017013) on April 3, 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. The mismatch between the code's nominal scope and actual recent solicitation activity suggests limited current pursuit opportunity under this specific Commodity designation.